For research and educational purposes only. Not medical advice.
Dihexa Reference
Educational, not medical advice reference for Dihexa: Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also known as Angiot…
Reference summary
Evidence is preclinical, centered on rodent cognition and synaptogenesis models plus medicinal-chemistry work on the AngIV analog. No human clinical efficacy or safety program is established.
- Categories
- Cognitive
- Aliases
- Angiotensin IV analog, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, PNB-0408
- Evidence posture
- preclinical — No established human clinical data.
- Regulatory status
- No FDA-approved Dihexa drug label. FDA lists Dihexa among bulk substances with safety-risk concerns.
- Content review status
- research reference